Cite
MLA Citation
U. Schindler et al.. “AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, leads to greater immune activation and reduced tumor growth when combined with chemotherapy.” European journal of cancer, vol. 92, n.d., pp. S14–S15. http://access.bl.uk/ark:/81055/vdc_100058290581.0x000030